ナルトレキソン・ブプレノルフィン市場、規模、シェア、動向、産業分析レポート：製品別、投与経路別、用途別、流通チャネル別、地域別-2025年～2034年市場予測

Polaris Market Research社の最新調査によると、ナルトレキソン・ブプレノルフィンの市場規模は2034年までに124億米ドルに達する見込みです。このレポートは現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

ナルトレキソン・ブプレノルフィンは、渇望を軽減し、再発を防ぐことによってオピオイド使用障害を治療するために使用される薬です。オピオイド使用障害の治療方法は、短期的な解毒から長期的な回復計画へとシフトしています。ヘルスケアの専門家たちは、薬物療法を継続することで回復の成果を高め、再発のリスクを下げることができると認識しています。ナルトレキソン・ブプレノルフィンはどちらも長期的な治療戦略で使用されるが、その理由は、治療への関与を維持し、薬物使用への回帰の可能性を減らすことができるからです。長期的なアプローチを採用する治療センターが増えるにつれ、長期にわたって安全に服用できる薬剤の必要性が高まっています。この動向は、さまざまな治療環境において、両薬剤の継続的な使用を支えています。

従来、オピオイド使用障害の治療は、主に依存症専門医が担当していたが、その状況は変わりつつあります。現在では、より多くのプライマリ・ケア提供者や一般開業医が、ナルトレキソン・ブプレノルフィンを用いた薬物補助療法を提供しています。これは、処方制限が緩和され、非専門医のトレーニングが強化されたことも一因です。患者は普段かかっている医師から治療を受けられるようになり、治療へのアクセスが容易になりました。この変化は、OUD治療が日常ヘルスケアに組み込まれることを助け、治療を開始・継続できる患者数を増加させています。アクセスが広がるにつれて、これらの薬剤の使用は増加の一途をたどると予想されます。

ナルトレキソン・ブプレノルフィン市場レポート・ハイライト

2024年には、オピオイドの離脱症状の管理や渇望の軽減に広く使用されていることから、ブプレノルフィン部門が大きなシェアを占める。

病院薬局セグメントは、過量投与や離脱症状を経験した患者の最初のケアポイントであることから、予測期間中に大きな成長が見込まれます。

2024年には、北米がnaltrexoneおよびbuprenorphine市場で最大のシェアを占め、オピオイド使用障害の高い有病率と治療へのアクセス拡大に向けた政府の強力な関与に牽引されました。

アジア太平洋のナルトレキソン・ブプレノルフィン市場は、薬物使用障害に対する意識の高まりと精神保健サービスの強化に向けた取り組みにより、著しい成長を遂げています。

世界の主な市場企業としては、Alkermes, Inc.、Camurus、Collegium Pharmaceutical、Indivior PLC、Orexo AB傘下のOrexo US, Inc.、Sun Pharmaceutical Industries Ltd.、Titan Pharmaceuticals, Inc.などが挙げられます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のナルトレキソン・ブプレノルフィン市場の洞察

• 市場スナップショット
• ナルトレキソン・ブプレノルフィンの市場力学
  • 促進要因と機会
    • オピオイド使用障害患者の増加
    • 政府の支援政策とプログラム
  • 抑制要因と課題
    • 初期投資額が高め
• PESTEL分析
• ナルトレキソン・ブプレノルフィンの市場動向
• バリューチェーン分析

第5章 世界のナルトレキソン・ブプレノルフィン市場：製品別

• 主な調査結果
• イントロダクション
• ナルトレキソン
• ブプレノルフィン

第6章 世界のナルトレキソン・ブプレノルフィン市場：投与経路別

• 主な調査結果
• イントロダクション
• 経口投与
• 注射剤投与
• 埋め込み型投与

第7章 世界のナルトレキソン・ブプレノルフィン市場：用途別

• 主な調査結果
• イントロダクション
• オピオイド使用障害（OUD）
• アルコール使用障害（AUD）

第8章 世界のナルトレキソン・ブプレノルフィン市場：流通チャネル別

• 主な調査結果
• イントロダクション
• 病院薬局
• 小売薬局
• その他

第9章 世界のナルトレキソン・ブプレノルフィン市場：地域別

• 主な調査結果
• イントロダクション
  • ナルトレキソン・ブプレノルフィンの市場評価：地域、2020年～2034年
• 北米
  • 北米：製品別、2020年～2034年
  • 北米：投与経路別、2020年～2034年
  • 北米：用途別、2020年～2034年
  • 北米：流通チャネル別、2020年～2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：製品別、2020年～2034年
  • 欧州：投与経路別、2020年～2034年
  • 欧州：用途別、2020年～2034年
  • 欧州：流通チャネル別、2020年～2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋：製品別、2020年～2034年
  • アジア太平洋：投与経路別、2020年～2034年
  • アジア太平洋：用途別、2020年～2034年
  • アジア太平洋：流通チャネル別、2020年～2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他のアジア太平洋
• 中東・アフリカ
  • 中東・アフリカ：製品別、2020年～2034年
  • 中東・アフリカ：投与経路別、2020年～2034年
  • 中東・アフリカ：用途別、2020年～2034年
  • 中東・アフリカ：流通チャネル別、2020年～2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東・アフリカ
• ラテンアメリカ
  • ラテンアメリカ：製品別、2020年～2034年
  • ラテンアメリカ：投与経路別、2020年～2034年
  • ラテンアメリカ：用途別、2020年～2034年
  • ラテンアメリカ：流通チャネル別、2020年～2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第10章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第11章 企業プロファイル

• Alkermes, Inc.
• Camurus
• Collegium Pharmaceutical
• Indivior PLC
• Orexo US, Inc.（a part of Orexo AB）
• Sun Pharmaceutical Industries Ltd
• Titan Pharmaceuticals, Inc.

List of Tables:

• Table 1 Global Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 2 Global Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 3 Global Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 4 Global Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 5 North America: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 6 North America: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 7 North America: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 8 North America: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 9 US: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 10 US: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 11 US: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 12 US: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 13 Canada: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 14 Canada: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 15 Canada: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 16 Canada: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 17 Europe: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 18 Europe: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 19 Europe: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 20 Europe: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 21 UK: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 22 UK: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 23 UK: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 24 UK: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 25 France: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 26 France: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 27 France: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 28 France: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 29 Germany: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 30 Germany: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 31 Germany: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 32 Germany: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 33 Italy: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 34 Italy: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 35 Italy: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 36 Italy: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 37 Spain: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 38 Spain: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 39 Spain: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 40 Spain: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 41 Netherlands: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 42 Netherlands: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 43 Netherlands: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 44 Netherlands: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 45 Russia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 46 Russia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 47 Russia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 48 Russia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 49 Rest of Europe: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 50 Rest of Europe: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 51 Rest of Europe: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 52 Rest of Europe: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 53 Asia Pacific: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 54 Asia Pacific: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 55 Asia Pacific: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 56 Asia Pacific: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 57 China: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 58 China: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 59 China: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 60 China: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 61 India: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 62 India: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 63 India: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 64 India: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 65 Malaysia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 66 Malaysia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 67 Malaysia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 68 Malaysia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 69 Japan: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 70 Japan: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 71 Japan: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 72 Japan: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 73 Indonesia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 74 Indonesia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 75 Indonesia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 76 Indonesia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 77 South Korea: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 78 South Korea: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 79 South Korea: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 80 South Korea: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 81 Australia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 82 Australia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 83 Australia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 84 Australia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 85 Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 86 Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 87 Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 88 Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 89 Middle East & Africa: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 90 Middle East & Africa: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 91 Middle East & Africa: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 92 Middle East & Africa: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 93 Saudi Arabia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 94 Saudi Arabia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 95 Saudi Arabia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 96 Saudi Arabia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 97 UAE: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 98 UAE: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 99 UAE: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 100 UAE: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 101 Israel: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 102 Israel: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 103 Israel: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 104 Israel: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 105 South Africa: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 106 South Africa: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 107 South Africa: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 108 South Africa: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 109 Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 110 Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 111 Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 112 Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 113 Latin America: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 114 Latin America: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 115 Latin America: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 116 Latin America: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 117 Mexico: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 118 Mexico: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 119 Mexico: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 120 Mexico: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 121 Brazil: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 122 Brazil: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 123 Brazil: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 124 Brazil: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 125 Argentina: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 126 Argentina: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 127 Argentina: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 128 Argentina: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• Table 129 Rest of Latin America: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• Table 130 Rest of Latin America: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• Table 131 Rest of Latin America: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
• Table 132 Rest of Latin America: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)

List of Figures:

• Figure 1. Global Naltrexone And Buprenorphine Market, 2020-2034 (USD billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Product
• Figure 7. Global Naltrexone And Buprenorphine Market, by Product, 2024 & 2034 (USD billion)
• Figure 8. Market by Route of Administration
• Figure 9. Global Naltrexone And Buprenorphine Market, by Route of Administration, 2024 & 2034 (USD billion)
• Figure 10. Market by Application
• Figure 11. Global Naltrexone And Buprenorphine Market, by Application, 2024 & 2034 (USD billion)
• Figure 12. Market by Distribution Channel
• Figure 13. Global Naltrexone And Buprenorphine Market, by Distribution Channel, 2024 & 2034 (USD billion)
• Figure 14. Global Naltrexone And Buprenorphine Market Assessment, By Geography, 2020-2034 (USD billion)
• Figure 15. Strategic Analysis - Global Naltrexone And Buprenorphine Market

The naltrexone and buprenorphine market size is expected to reach USD 12.40 billion by 2034, according to a new study by Polaris Market Research. The report "Naltrexone and Buprenorphine Market Size, Share, Trends, Industry Analysis Report By Product (Naltrexone, Buprenorphine), By Route of Administration, By Application, By Distribution Channel, By Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Naltrexone and buprenorphine are medications used to treat opioid use disorder by reducing cravings and preventing relapse. There is a shift in how opioid use disorder is being treated from short-term detox to long-term recovery planning. Healthcare professionals now recognize that continued medication support can improve recovery outcomes and lower relapse risks. Naltrexone and buprenorphine are both used in long-term treatment strategies because they help people stay engaged in care and reduce the chance of returning to drug use. As more treatment centers adopt a long-term approach, the need for medications that can be taken safely over time increases. This trend supports continued growth in the use of both medications across various care settings.

Traditionally, treatment for opioid use disorder was handled mostly by addiction specialists, but this is changing. Now, more primary care providers and general practitioners are offering medication-assisted treatment using naltrexone and buprenorphine. This is partly due to reduced prescribing restrictions and increased training for non-specialists. Patients can now receive treatment from their regular doctors, making it easier to access care. This shift is helping integrate OUD treatment into everyday healthcare, which increases the number of patients who can start and continue treatment. As access widens, use of these medications is expected to keep rising.

Naltrexone and Buprenorphine Market Report Highlights

In 2024, the buprenorphine segment dominated with a larger share due to its widespread use in managing opioid withdrawal symptoms and reducing cravings.

The hospitals pharmacies segment is expected to experience significant growth during the forecast period, as hospitals are the first point of care for individuals experiencing overdose or withdrawal.

In 2024, North America dominated the naltrexone and buprenorphine market with the largest share driven by the high prevalence of opioid use disorder and strong government involvement in expanding access to treatment.

The Asia Pacific naltrexone and buprenorphine market is experiencing significant growth, due to growing awareness of substance use disorders and efforts to strengthen mental health services.

A few global key market players are Alkermes, Inc.; Camurus; Collegium Pharmaceutical; Indivior PLC; Orexo US, Inc. (a part of Orexo AB); Sun Pharmaceutical Industries Ltd; and Titan Pharmaceuticals, Inc.

Polaris market research has segmented the naltrexone and buprenorphine market report based on product, route of administration, application, distribution channel, and region:

By Product (Revenue - USD Billion, 2020-2034)

Naltrexone

Buprenorphine

BELBUCA

Sublocade

Suboxone

Zubsolv

Others

By Route of Administration (Revenue - USD Billion, 2020-2034)

Oral Administration

Injectable Administration

Implantable Administration

By Application (Revenue - USD Billion, 2020-2034)

Opioid Use Disorder (OUD)

Alcohol Use Disorder (AUD)

By Distribution Channel (Revenue - USD Billion, 2020-2034)

Hospitals Pharmacies

Retail Pharmacies

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of APAC

Latin America

Argentina

Brazil

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of MEA

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Naltrexone And Buprenorphine Market Insights

• 4.1. Naltrexone And Buprenorphine Market - Market Snapshot
• 4.2. Naltrexone And Buprenorphine Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Growing Number of People with Opioid Use Disorder
    • 4.2.1.2. Supportive Government Policies and Programs
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High Initial Investment
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Naltrexone And Buprenorphine Market Trends
• 4.6. Value Chain Analysis

5. Global Naltrexone And Buprenorphine Market, by Product

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
• 5.3. Naltrexone
  • 5.3.1. Global Naltrexone And Buprenorphine Market, by Naltrexone, by Region, 2020-2034 (USD billion)
• 5.4. Buprenorphine
  • 5.4.1. Global Naltrexone And Buprenorphine Market, by Buprenorphine, by Region, 2020-2034 (USD billion)
  • 5.4.2. BELBUCA
    • 5.4.2.1. Global Naltrexone And Buprenorphine Market, by BELBUCA, by Region, 2020-2034 (USD billion)
  • 5.4.3. Sublocade
    • 5.4.3.1. Global Naltrexone And Buprenorphine Market, by Sublocade, by Region, 2020-2034 (USD billion)
  • 5.4.4. Suboxone
    • 5.4.4.1. Global Naltrexone And Buprenorphine Market, by Suboxone, by Region, 2020-2034 (USD billion)
  • 5.4.5. Zubsolv
    • 5.4.5.1. Global Naltrexone And Buprenorphine Market, by Zubsolv, by Region, 2020-2034 (USD billion)
  • 5.4.6. Others
    • 5.4.6.1. Global Naltrexone And Buprenorphine Market, by Others, by Region, 2020-2034 (USD billion)

6. Global Naltrexone And Buprenorphine Market, by Route of Administration

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
• 6.3. Oral Administration
  • 6.3.1. Global Naltrexone And Buprenorphine Market, by Oral Administration, by Region, 2020-2034 (USD billion)
• 6.4. Injectable Administration
  • 6.4.1. Global Naltrexone And Buprenorphine Market, by Injectable Administration, by Region, 2020-2034 (USD billion)
• 6.5. Implantable Administration
  • 6.5.1. Global Naltrexone And Buprenorphine Market, by Implantable Administration, by Region, 2020-2034 (USD billion)

7. Global Naltrexone And Buprenorphine Market, by Application

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Naltrexone And Buprenorphine Market, by Medical Biotechnology, 2020-2034 (USD billion)
• 7.3. Opioid use disorder (OUD)
  • 7.3.1. Global Naltrexone And Buprenorphine Market, by Opioid use disorder (OUD), by Region, 2020-2034 (USD billion)
• 7.4. Alcohol use disorder (AUD)
  • 7.4.1. Global Naltrexone And Buprenorphine Market, by Alcohol use disorder (AUD), by Region, 2020-2034 (USD billion)

8. Global Naltrexone And Buprenorphine Market, by Distribution Channel

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• 8.3. Hospitals Pharmacies
  • 8.3.1. Global Naltrexone And Buprenorphine Market, by Hospitals Pharmacies, by Region, 2020-2034 (USD billion)
• 8.4. Retail Pharmacies
  • 8.4.1. Global Naltrexone And Buprenorphine Market, by Retail Pharmacies, by Region, 2020-2034 (USD billion)
• 8.5. Others
  • 8.5.1. Global Naltrexone And Buprenorphine Market, by Others, by Region, 2020-2034 (USD billion)

9. Global Naltrexone And Buprenorphine Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Naltrexone And Buprenorphine Market Assessment, By Geography, 2020-2034 (USD billion)
• 9.3. Naltrexone And Buprenorphine Market - North America
  • 9.3.1. North America: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • 9.3.2. North America: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • 9.3.3. North America: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • 9.3.4. North America: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.3.5. Naltrexone And Buprenorphine Market - US
    • 9.3.5.1. US: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.3.5.2. US: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.3.5.3. US: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.3.5.4. US: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.3.6. Naltrexone And Buprenorphine Market - Canada
    • 9.3.6.1. Canada: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.3.6.2. Canada: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.3.6.3. Canada: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.3.6.4. Canada: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• 9.4. Naltrexone And Buprenorphine Market - Europe
  • 9.4.1. Europe: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • 9.4.2. Europe: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • 9.4.3. Europe: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • 9.4.4. Europe: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.4.5. Naltrexone And Buprenorphine Market - UK
    • 9.4.5.1. UK: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.4.5.2. UK: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.4.5.3. UK: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.4.5.4. UK: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.4.6. Naltrexone And Buprenorphine Market - France
    • 9.4.6.1. France: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.4.6.2. France: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.4.6.3. France: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.4.6.4. France: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.4.7. Naltrexone And Buprenorphine Market - Germany
    • 9.4.7.1. Germany: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.4.7.2. Germany: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.4.7.3. Germany: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.4.7.4. Germany: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.4.8. Naltrexone And Buprenorphine Market - Italy
    • 9.4.8.1. Italy: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.4.8.2. Italy: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.4.8.3. Italy: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.4.8.4. Italy: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.4.9. Naltrexone And Buprenorphine Market - Spain
    • 9.4.9.1. Spain: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.4.9.2. Spain: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.4.9.3. Spain: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.4.9.4. Spain: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.4.10. Naltrexone And Buprenorphine Market - Netherlands
    • 9.4.10.1. Netherlands: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.4.10.2. Netherlands: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.4.10.3. Netherlands: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.4.10.4. Netherlands: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.4.11. Naltrexone And Buprenorphine Market - Russia
    • 9.4.11.1. Russia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.4.11.2. Russia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.4.11.3. Russia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.4.11.4. Russia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.4.12. Naltrexone And Buprenorphine Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.4.12.2. Rest of Europe: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.4.12.3. Rest of Europe: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.4.12.4. Rest of Europe: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• 9.5. Naltrexone And Buprenorphine Market - Asia Pacific
  • 9.5.1. Asia Pacific: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • 9.5.2. Asia Pacific: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • 9.5.3. Asia Pacific: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • 9.5.4. Asia Pacific: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.5.5. Naltrexone And Buprenorphine Market - China
    • 9.5.5.1. China: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.5.5.2. China: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.5.5.3. China: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.5.5.4. China: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.5.6. Naltrexone And Buprenorphine Market - India
    • 9.5.6.1. India: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.5.6.2. India: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.5.6.3. India: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.5.6.4. India: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.5.7. Naltrexone And Buprenorphine Market - Malaysia
    • 9.5.7.1. Malaysia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.5.7.2. Malaysia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.5.7.3. Malaysia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.5.7.4. Malaysia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.5.8. Naltrexone And Buprenorphine Market - Japan
    • 9.5.8.1. Japan: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.5.8.2. Japan: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.5.8.3. Japan: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.5.8.4. Japan: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.5.9. Naltrexone And Buprenorphine Market - Indonesia
    • 9.5.9.1. Indonesia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.5.9.2. Indonesia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.5.9.3. Indonesia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.5.9.4. Indonesia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.5.10. Naltrexone And Buprenorphine Market - South Korea
    • 9.5.10.1. South Korea: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.5.10.2. South Korea: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.5.10.3. South Korea: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.5.10.4. South Korea: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.5.11. Naltrexone And Buprenorphine Market - Australia
    • 9.5.11.1. Australia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.5.11.2. Australia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.5.11.3. Australia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.5.11.4. Australia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.5.12. Naltrexone And Buprenorphine Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.5.12.2. Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.5.12.3. Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.5.12.4. Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• 9.6. Naltrexone And Buprenorphine Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • 9.6.2. Middle East & Africa: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • 9.6.3. Middle East & Africa: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • 9.6.4. Middle East & Africa: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.6.5. Naltrexone And Buprenorphine Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.6.5.2. Saudi Arabia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.6.5.3. Saudi Arabia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.6.5.4. Saudi Arabia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.6.6. Naltrexone And Buprenorphine Market - UAE
    • 9.6.6.1. UAE: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.6.6.2. UAE: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.6.6.3. UAE: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.6.6.4. UAE: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.6.7. Naltrexone And Buprenorphine Market - Israel
    • 9.6.7.1. Israel: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.6.7.2. Israel: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.6.7.3. Israel: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.6.7.4. Israel: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.6.8. Naltrexone And Buprenorphine Market - South Africa
    • 9.6.8.1. South Africa: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.6.8.2. South Africa: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.6.8.3. South Africa: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.6.8.4. South Africa: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.6.9. Naltrexone And Buprenorphine Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.6.9.2. Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.6.9.3. Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.6.9.4. Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
• 9.7. Naltrexone And Buprenorphine Market - Latin America
  • 9.7.1. Latin America: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • 9.7.2. Latin America: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • 9.7.3. Latin America: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • 9.7.4. Latin America: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.7.5. Naltrexone And Buprenorphine Market - Mexico
    • 9.7.5.1. Mexico: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.7.5.2. Mexico: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.7.5.3. Mexico: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.7.5.4. Mexico: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.7.6. Naltrexone And Buprenorphine Market - Brazil
    • 9.7.6.1. Brazil: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.7.6.2. Brazil: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.7.6.3. Brazil: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.7.6.4. Brazil: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.7.7. Naltrexone And Buprenorphine Market - Argentina
    • 9.7.7.1. Argentina: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.7.7.2. Argentina: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.7.7.3. Argentina: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.7.7.4. Argentina: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.7.8. Naltrexone And Buprenorphine Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.7.8.2. Rest of Latin America: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.7.8.3. Rest of Latin America: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.7.8.4. Rest of Latin America: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Alkermes, Inc.
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Camurus
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Collegium Pharmaceutical
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Indivior PLC
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Orexo US, Inc. (a part of Orexo AB)
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. Sun Pharmaceutical Industries Ltd
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. Titan Pharmaceuticals, Inc.
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development